En la esclerosis sistémica, el esófago se afecta en un 90%, seguido de los tramos anorrectal (%), gástrico ( 70%), colon (%) e intestino delgado. La esclerodermia es un relativamente infrecuente enfermedad reumática autoinmunitaria que afecta la piel y otros órganos del cuerpo. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.

Author: Tygokinos Mijin
Country: Sri Lanka
Language: English (Spanish)
Genre: Relationship
Published (Last): 20 March 2017
Pages: 133
PDF File Size: 17.30 Mb
ePub File Size: 9.99 Mb
ISBN: 390-4-34751-958-2
Downloads: 82285
Price: Free* [*Free Regsitration Required]
Uploader: Nam

Double-blind, multicenter controlled trial comparing topical dimethyl sulfoxide and normal saline for treatment of hand ulcers in patients with systemic sclerosis. Are you a health professional able to prescribe or dispense drugs? J Rheumatol, 11pp. Ann Pharmacother, 40pp. Comparison between iloprost and alprostadil in the treatment of Raynaud’s phenomenon.

Raynaud’s phenomenon in mixed connective tissue disease. Severe refractory fingertip ulcerations in a patient with scleroderma: Semin Arthritis Rheum, 13pp. Arthritis Rheum, 28pp.


Hemorragia por telangiectasias en paciente con esclerosis sistémica

Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis. Scleroderma pericardial disease presented with a large pericardial effusion -a case report. The knowledge of the pathogenesis of systemic sclerosis to molecular level will lead to new treatment strategies. Am J Cardiol, 83pp. J Rheumatol, 32pp.

Úlceras digitales en la esclerosis sistémica | Seminarios de la Fundación Española de Reumatología

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. Antiendothelial cell antibodies in scleroderma correlated with severe digital ischemia and pulmonary arterial hypertension. Treatment of severe Raynaud’s phenomenon in collagen diseases with alprostadil IV. Pathologic observations in systemic sclerosis scleroderma. Assessment of vascular function in systemic sclerosis: Mechanisms and consequences of fibrosis in systemic sclerosis [review].

Digital ulcers in systemic sclerosis.

Drugs, 4pp. Symptoms of Raynaud phenomenon in an inner-city African-American community.

Calcium channel blockers for primary Raynaud’s phenomenon: Alteration of arterial distensibility in systemic sclerosis. Ann Intern Med,pp.


There was a problem providing the content you requested

J Rheumatol, 16pp. Br Heart J, 42pp. Lancet,pp. Morphologic changes in the digital arteries of patients with progressive systemic sclerosis scleroderma and Raynaud phenomenon.

Medicine Baltimore64pp. Rheumatology Oxford44pp. Patients with skeletal myositis are more likely to develop congestive heart failure, sustained symptomatic arrythmias, and cardiac sudden death.

Long-term low molecular weight heparin therapy for severe Raynaud’s phenomenon: Increased alfa-2 adrenergic constriction of isolated arterioles in diffuse scleroderma. J Rheumatol, 12pp. Clin Rheumatol, 14pp.